By Annalee Armstrong, Gabrielle Masson, James Waldron, Max Bayer, Ben Adams - Fierce Biotech We're off for another day of the J.P. Morgan Healthcare Conference 2024. The flood of licensing deals and M&A may have slowed, but there's still plenty of action to come...

By Eve Herold - Time - Ideas • Technology - When people hear the words “social engineering,” they usually think of the supposed nefarious designs of government or an opposing political party. These days, there’s a general sense of social upheaval brought on by some...

by Michael Carey, PhD - UCLA Health - A study by UCLA scientists has uncovered significant insights into stem cell aging, specifically in neural stem and progenitor cells (NSPCs) in the mouse brain. The research reveals that NSPC aging is primarily characterized by a...

By Carrie Arnold & Paul Webster - Nature Medicine - Nature Medicine asks leading researchers to name their top clinical trial for 2024, from base editing and a vaccine against HIV to artificial intelligence tools for lung cancer and patient triage. Pharma’s ongoing...

By Emily Mullin - Wired- “It was a circus, bouncing from specialist to specialist and constantly desecrating my body with endless amounts of prescription pills, all in the hopes of finding a sliver of what it feels like to be alive,” Olaghere told an advisory...

By James Zou, PhD - Targeted Oncology (click here for video) - James Zou, PhD, assistant professor of biomedical data science at Stanford University, discusses machine learning and the different ways oncologists are utilizing it for the management, treatment, and...

By: Brooklyn Draisey - Iowa Capital Dispatch - Findings from a group of Iowa State University researchers could lead to the ability to create new blood stem cells from a patient’s own blood, possibly doing away with the need for bone marrow transplants. ISU assistant...

By William A. Haseltine - Forbes - In 1999, I defined regenerative medicine as the collection of interventions that restore to normal function tissues and organs that have been damaged by disease, injured by trauma, or worn by time. I include a full spectrum of...

By Matthew Tontonoz - Memorial Sloan Kettering Cancer Center When Christopher Klebanoff, MD, came to Memorial Sloan Kettering Cancer Center (MSK) from the National Cancer Institute in 2016, he was focused on a singular goal: bringing the promise of cellular...

by Weil Cornell Medicine - A drug screening system that models cancers using lab-grown tissues called organoids has helped uncover a promising target for future pancreatic cancer treatments, according to a new study from researchers at Weill Cornell Medicine. In the...

One of the 2023 highlights for #regenerativemedicinefoundation was our special project- World Stem Cell Summit in June at the fabulous #InnovationQuarter in #visitWinstonSalem- The 20th annual Summit was combined with the #WFIRM Regenerative Medicine Essentials Course...

By Alvin Powell - The Harvard Gazette - The Food and Drug Administration announced last week that it’s investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care over...